rs121912664
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
|
|
|
rs1555526250
|
|
AGGTCT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782620
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs11540652
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
|
9569050 |
1998 |
rs28934576
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
|
9569050 |
1998 |
rs1042522
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our aim was to evaluate association of R72P with breast cancer risk as well as histopathologic features of the breast tumors and survival.
|
16033823 |
2005 |
rs1131691014
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Our aim was to evaluate association of R72P with breast cancer risk as well as histopathologic features of the breast tumors and survival.
|
16033823 |
2005 |
rs878854066
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Our aim was to evaluate association of R72P with breast cancer risk as well as histopathologic features of the breast tumors and survival.
|
16033823 |
2005 |
rs11540652
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
|
16489069 |
2006 |
rs121912651
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
|
16489069 |
2006 |
rs28934576
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
|
16489069 |
2006 |
rs1042522
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival.
|
20021639 |
2009 |
rs1131691014
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival.
|
20021639 |
2009 |
rs878854066
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival.
|
20021639 |
2009 |
rs587781858
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival.
|
20021639 |
2009 |
rs1042522
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Taken together, we showed the preferential loss of the rs1042522 C allele, which is protective against BC progression, in breast tumors.
|
21810023 |
2011 |
rs121912664
|
|
|
0.710 |
GeneticVariation |
BEFREE |
A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.
|
23794094 |
2013 |
rs17849781
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB.
|
25105660 |
2014 |
rs28934874
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB.
|
25105660 |
2014 |
rs11540654
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB.
|
25105660 |
2014 |
rs876660254
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB.
|
25105660 |
2014 |
rs17849781
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs17849781
|
|
T |
0.710 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs28934874
|
|
T |
0.710 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs28934874
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |